These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 10199158)
21. Insulin lispro improves postprandial glucose control in patients with diabetes mellitus. Skrha J; Smahelová A; Andĕl M; Vrtovec M; Subić J; Kreze A; Vozar J; Korecová M; de Verga V; Wyatt J; Metcalfe S; Ristić S Sb Lek; 2002; 103(1):15-21. PubMed ID: 12448933 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp. Heinemann L; Weyer C; Rave K; Stiefelhagen O; Rauhaus M; Heise T Exp Clin Endocrinol Diabetes; 1997; 105(3):140-4. PubMed ID: 9228509 [TBL] [Abstract][Full Text] [Related]
23. Advances in the treatment of diabetes-insulin analogues. Vajo Z; Duckworth WC Minerva Endocrinol; 2002 Sep; 27(3):167-80. PubMed ID: 12091792 [TBL] [Abstract][Full Text] [Related]
25. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus. Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120 [TBL] [Abstract][Full Text] [Related]
26. The human insulin analogue insulin lispro. Koivisto VA Ann Med; 1998 Jun; 30(3):260-6. PubMed ID: 9677011 [TBL] [Abstract][Full Text] [Related]
27. [Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability]. Yokono K Nihon Rinsho; 2001 Nov; 59(11):2127-33. PubMed ID: 11712396 [TBL] [Abstract][Full Text] [Related]
28. Are presently available insulin analogues clinically beneficial? Berger M; Heinemann L Diabetologia; 1997 Jul; 40 Suppl 2():S91-6. PubMed ID: 9248708 [TBL] [Abstract][Full Text] [Related]
29. Insulin analogues and management of diabetes mellitus. Vaidyanathan B; Menon PS Indian J Pediatr; 2000 Jun; 67(6):435-41. PubMed ID: 10932964 [TBL] [Abstract][Full Text] [Related]
36. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues. Whittingham JL; Edwards DJ; Antson AA; Clarkson JM; Dodson GG Biochemistry; 1998 Aug; 37(33):11516-23. PubMed ID: 9708987 [TBL] [Abstract][Full Text] [Related]
37. Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment. Heise T; Heinemann L Curr Pharm Des; 2001 Sep; 7(14):1303-25. PubMed ID: 11472271 [TBL] [Abstract][Full Text] [Related]
38. Monomeric insulins and their experimental and clinical implications. Brange J; Owens DR; Kang S; Vølund A Diabetes Care; 1990 Sep; 13(9):923-54. PubMed ID: 2226110 [TBL] [Abstract][Full Text] [Related]